Patent AnalyticsExaminers
Menu

Application

14804407 · NEPRILYSIN INHIBITORS

Filed 2015-07-21 · Granted · Patent 9555041 (2017-01-31) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Kamal A Saeed Easy · CPC C07C 281/02 · THERAVANCE BIOPHARMA US, INC.

Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
10.6 mo
to disposition 18.4 mo
Statutes raised
DP
1 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in